Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Antiproliferative and apoptotic effects of the oxidative dimerization product of methyl caffeate on human breast cancer cells.

Bailly F, Toillon RA, Tomavo O, Jouy N, Hondermarck H, Cotelle P.

Bioorg Med Chem Lett. 2013 Jan 15;23(2):574-8. doi: 10.1016/j.bmcl.2012.11.009. Epub 2012 Nov 22.

PMID:
23228470
2.

Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells.

Serafim TL, Carvalho FS, Marques MP, Calheiros R, Silva T, Garrido J, Milhazes N, Borges F, Roleira F, Silva ET, Holy J, Oliveira PJ.

Chem Res Toxicol. 2011 May 16;24(5):763-74. doi: 10.1021/tx200126r. Epub 2011 Apr 28.

PMID:
21504213
3.

Synthesis and antiproliferative activity of two diastereomeric lignan amides serving as dimeric caffeic acid-l-DOPA hybrids.

Magoulas GE, Rigopoulos A, Piperigkou Z, Gialeli C, Karamanos NK, Takis PG, Troganis AN, Chrissanthopoulos A, Maroulis G, Papaioannou D.

Bioorg Chem. 2016 Jun;66:132-44. doi: 10.1016/j.bioorg.2016.04.003. Epub 2016 Apr 23.

PMID:
27155809
4.

2-(3,5-Dihydroxyphenyl)-6-hydroxybenzothiazole arrests cell growth and cell cycle and induces apoptosis in breast cancer cell lines.

Rajabi M.

DNA Cell Biol. 2012 Mar;31(3):388-91. doi: 10.1089/dna.2011.1363. Epub 2011 Aug 12.

PMID:
21838530
5.

In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid.

Chakravarti B, Maurya R, Siddiqui JA, Bid HK, Rajendran SM, Yadav PP, Konwar R.

J Ethnopharmacol. 2012 Jun 26;142(1):72-9.

PMID:
22855944
6.

Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action.

Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, Gravanis A, Castanas E.

Breast Cancer Res. 2004;6(2):R63-74. Epub 2003 Dec 15.

7.

Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.

Kanaan YM, Das JR, Bakare O, Enwerem NM, Berhe S, Beyene D, Williams V, Zhou Y, Copeland RL Jr.

Anticancer Res. 2009 Jan;29(1):191-9.

8.

Phenolic acid derivatives with potential anticancer properties--a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids.

Fiuza SM, Gomes C, Teixeira LJ, Girão da Cruz MT, Cordeiro MN, Milhazes N, Borges F, Marques MP.

Bioorg Med Chem. 2004 Jul 1;12(13):3581-9.

PMID:
15186842
9.

Anticancer (hexacarbonyldicobalt)propargyl aryl ethers: synthesis, antiproliferative activity, apoptosis induction, and effect on cellular oxidative stress.

Schimler SD, Hall DJ, Debbert SL.

J Inorg Biochem. 2013 Feb;119:28-37. doi: 10.1016/j.jinorgbio.2012.10.014. Epub 2012 Nov 7.

PMID:
23178649
10.

The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.

Czeczuga-Semeniuk E, Wołczyński S, Dabrowska M, Dziecioł J, Anchim T.

Folia Histochem Cytobiol. 2004;42(4):221-7.

11.

Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.

Lin WL, Lee YJ, Wang SM, Huang PY, Tseng TH.

Eur J Pharmacol. 2012 Apr 5;680(1-3):8-15. doi: 10.1016/j.ejphar.2012.01.032. Epub 2012 Feb 10.

PMID:
22329896
12.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
14.

Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.

Xia CN, Li HB, Liu F, Hu WX.

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6553-7. doi: 10.1016/j.bmcl.2008.10.046. Epub 2008 Oct 15.

PMID:
18952420
15.

Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells.

Choi EJ, Bae SM, Ahn WS.

Arch Pharm Res. 2008 Oct;31(10):1281-5. doi: 10.1007/s12272-001-2107-0. Epub 2008 Oct 29.

PMID:
18958418
16.

Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.

Nizamutdinova IT, Lee GW, Son KH, Jeon SJ, Kang SS, Kim YS, Lee JH, Seo HG, Chang KC, Kim HJ.

Int J Oncol. 2008 Sep;33(3):485-91.

PMID:
18695877
17.

Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism.

Grossmann ME, Mizuno NK, Dammen ML, Schuster T, Ray A, Cleary MP.

Cancer Prev Res (Phila). 2009 Oct;2(10):879-86. doi: 10.1158/1940-6207.CAPR-09-0088. Epub 2009 Sep 29.

18.

Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231.

Kim JB, Lee KM, Ko E, Han W, Lee JE, Shin I, Bae JY, Kim S, Noh DY.

Planta Med. 2008 Jan;74(1):39-42. doi: 10.1055/s-2007-993779. Epub 2008 Jan 17.

PMID:
18203057
19.
20.

CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.

Wang X, Osada T, Wang Y, Yu L, Sakakura K, Katayama A, McCarthy JB, Brufsky A, Chivukula M, Khoury T, Hsu DS, Barry WT, Lyerly HK, Clay TM, Ferrone S.

J Natl Cancer Inst. 2010 Oct 6;102(19):1496-512. doi: 10.1093/jnci/djq343. Epub 2010 Sep 17.

Supplemental Content

Support Center